Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm-Reference-Cited by-同舟云学术

Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm

Published:2020-02-07 Issue:1 Volume:28 Page:191-208
ISSN:2008-2231
Container-title:DARU Journal of Pharmaceutical Sciences
language:en
Short-container-title:DARU J Pharm Sci

Author:

Singh Dilpreet,Singh Amrit Pal,Singh Drishtant,Kesavan Anup Kumar,Arora Saroj,Tiwary Ashok K.,Bedi Neena

Publisher

Springer Science and Business Media LLC

Subject

Applied Mathematics,General Mathematics

Link

http://link.springer.com/content/pdf/10.1007/s40199-020-00330-3.pdf

Reference49 articles.

1. Said S, Hernandez GT. Sodium glucose co-transporter 2 (SGLT2) inhibition with canagliflozin in type 2 diabetes mellitus. Cardiovasc Hematol Agents Med Chem. 2013;11:203–6.

2. Davidson JA, Kuritzky L. Sodium glucose co-transporter 2 inhibitors and their mechanism for improving glycemia in patients with type 2 diabetes. Postgrad Med. 2014;126:33–48.

3. Whalen K, Miller S, Onge ES. The role of sodium glucose co-transporter 2 inhibitors in the treatment of type 2 diabetes. Clin Ther. 2015;37:1150–66.

4. Singh D, Tiwary AK, Bedi N. Canagliflozin loaded SMEDDS: formulation optimization for improved solubility, permeability and pharmacokinetic performance. J Pharm Investig. 2018;49:67–85.

5. Obadalova I, Dammer O, Jaroslava S, Krejcik L, Ridvan L, Marcela T. Complexes of canagliflozin and cyclodextrins US Patent (WO2016041530A1) (2016).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly(allylamine)-adorned heptylcarboxymethyl galactomannan nanocarriers of canagliflozin for controlling type-2 diabetes: Optimization by Box-Behnken design and in vivo performance;International Journal of Biological Macromolecules;2024-10

2. Ex vivo permeability study and in vitro solubility characterization of oral Canagliflozin self-nanomicellizing solid dispersion using Soluplus^® as a nanocarrier;Acta Marisiensis - Seria Medica;2024-06-01

3. Enhancement of the Dissolution and Solubility of Canagliflozin Using Nanodispersion Systems;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-03-16

4. Rosuvastatin-loaded solid SMEDDS: an innovative approach for solubility augmentation and improved pharmacodynamic profile;Journal of Dispersion Science and Technology;2024-01-04

5. Improved dissolution and pharmacokinetics of insufficiently water-soluble canagliflozin in solid dispersions with gelucire 50/13 as a drug carrier;2023-11-02